The article summarizes the cornestones of inicitating the pharmacotherapy of hypertension and dyslipidemia. The intervention of dyslipidemia should not be delayed after the intervention of hypertension.
The compliance and the adhrence are far from ideal. The physicians should support their patients with an appropriate approach.
Vascular age should be used for the explanation of the cardiovascular risk.